![Søren Bregenholt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Søren Bregenholt
Vorstandsvorsitzender bei
ALLIGATOR BIOSCIENCE AB
Profil
Søren Bregenholt currently works at Alligator Bioscience AB, as Chief Executive Officer from 2021, Medicon Valley Alliance FMBA, as Chairman, A Bioscience Incentive AB, as Chairman, Atlas Therapeutics AB, as Chairman, and Oblique Therapeutics AB, as Director.
Dr. Bregenholt also formerly worked at Macrophage Pharma Ltd., as Chief Executive Officer & Director, Novo Nordisk A, as Investment Manager, and Symphogen A, as Chief Operating Officer.
Dr. Bregenholt received his doctorate degree from the University of Copenhagen.
Aktuelle Nachrichten zu Søren Bregenholt
Aktive Positionen von Søren Bregenholt
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Vorstandsvorsitzender | 01.06.2021 |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Vorsitzender | - |
A Bioscience Incentive AB | Vorsitzender | - |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Vorsitzender | - |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Søren Bregenholt
| Unternehmen | Position | Ende |
|---|---|---|
| NOVO NORDISK A/S | Chief Investment Officer | - |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Vorstandsvorsitzender | - |
Symphogen A/S
 Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Geschäftsführer | - |
Ausbildung von Søren Bregenholt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
14
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
Medicon Valley Alliance FMBA
Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Operates Danish-Swedish life science cluster Medicon Valley | Commercial Services |
Atlas Therapeutics AB
Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibodies drugs | Health Technology |
A Bioscience Incentive AB | |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops and manufactures antibody drugs with predictable properties | Health Technology |
